244 related articles for article (PubMed ID: 6746149)
1. Incidence of isoniazid acetylation phenotypes in North Indians.
Gupta RC; Nair CR; Jindal SK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
[TBL] [Abstract][Full Text] [Related]
2. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
3. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
4. Acetylation phenotype profile in north Indian children with pulmonary tuberculosis.
Seth V; Beotra A; Ray D
Indian Pediatr; 1987 Nov; 24(11):1007-10. PubMed ID: 3450638
[No Abstract] [Full Text] [Related]
5. [Genetic polymorphism of isoniazid acetylation in Chilean patients with tuberculosis].
Ligueros M; Cruz Coke R; Neira S; Saavedra H; Kramer V; Prieto JC; Gelman M; Saavedra A; Nuñez A; Pescio S
Rev Med Chil; 1989 Dec; 117(12):1339-43. PubMed ID: 2519370
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
[TBL] [Abstract][Full Text] [Related]
7. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
[TBL] [Abstract][Full Text] [Related]
8. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
[TBL] [Abstract][Full Text] [Related]
9. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
[TBL] [Abstract][Full Text] [Related]
10. Sulphamethoxazole acetylation in fast and slow acetylators.
Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
[TBL] [Abstract][Full Text] [Related]
11. Use of sulphadimidine acetylation test in determining isoniazid inactivation rate in tuberculous patients.
Sen PK; Chatterjee R; Saha JR
Indian J Med Res; 1972 Jan; 60(1):28-39. PubMed ID: 5029122
[No Abstract] [Full Text] [Related]
12. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
Ellard GA
Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
[TBL] [Abstract][Full Text] [Related]
13. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
Nair CR; Gupta RC; Varshneya AK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
[TBL] [Abstract][Full Text] [Related]
14. [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
Kohno H; Mori M; Katayama T
Kekkaku; 1993 Aug; 68(8):511-6. PubMed ID: 8377325
[TBL] [Abstract][Full Text] [Related]
15. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
Zysset T; Peretti E
Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid acetylation metabolic ratio during maturation in children.
Pariente-Khayat A; Rey E; Gendrel D; Vauzelle-Kervroëdan F; Crémier O; d'Athis P; Badoual J; Olive G; Pons G
Clin Pharmacol Ther; 1997 Oct; 62(4):377-83. PubMed ID: 9357388
[TBL] [Abstract][Full Text] [Related]
17. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.
Ellard GA; Gammon PT
Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424
[TBL] [Abstract][Full Text] [Related]
18. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768
[TBL] [Abstract][Full Text] [Related]
19. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
[TBL] [Abstract][Full Text] [Related]
20. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
Dubbels R; Kattner E; Sell-Maurer D; Schloot W
Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
